Status:
UNKNOWN
Tomosymthesis for Breast Mass Lesion Characterization
Lead Sponsor:
Asmaa Abdelmonem Ahmed
Collaborating Sponsors:
Assiut University
Conditions:
Female Breast Cancer
Eligibility:
FEMALE
35+ years
Brief Summary
To Estimate diagnostic value of tomo synthesis for breast mass lesions characterization ( shape, margin, and density, detail of mass margins, Differences in mass density , Tumor measurement,.)
Detailed Description
Breast lesions are observed in about 20% of female patients1. However this percentage is likely to represent an underestimation of the true incidence of these lesions because breast imaging (MRI, ultr...
Eligibility Criteria
Inclusion
- female patients who undergoes DBT must have a compressed breast thickness of more than 2 cm,with small mass,age\>35,not have mastitis,not proceed breast implant
Exclusion
- Female Patients with breast implant ,severe nipple discharge, large palpable mass, mastitis and women within reproductive age(15-35 ) Female patients with huge breast that may exceed the detector size requirements for global diagnostic DBT.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04863833
Start Date
September 1 2021
End Date
October 1 2023
Last Update
April 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.